Skip to main content

PAN 5 Pill - white capsule/oblong

Pill with imprint PAN 5 is White, Capsule/Oblong and has been identified as Pancrelipase Delayed-Release 16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease. It is supplied by X-GEN Pharmaceuticals, Inc.

Pancrelipase is used in the treatment of Pancreatic Exocrine Dysfunction; Chronic Pancreatitis; Cystic Fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancrelipase 16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for PAN 5

Pancrelipase delayed-release 16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease PAN 5

Pancrelipase Delayed-Release

Imprint
PAN 5
Strength
16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease
Color
White
Shape
Capsule/Oblong
Availability
Rx and/or OTC
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
X-GEN Pharmaceuticals, Inc.
National Drug Code (NDC)
39822-0205 (Discontinued)
Inactive Ingredients
croscarmellose sodium, hydrogenated castor oil, silicon dioxide, microcrystalline cellulose, magnesium stearate, magnesium silicate, triethyl citrate, hypromellose phthalate (31% phthalate, 170 cst), carrageenan, potassium chloride, titanium dioxide, hypromelloses, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "PAN 5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.